BMO Capital Upgrades Regeneron Pharma (REGN) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq ends down as chipmakers fall and bank earnings roll in
- Oil prices settle mixed, focus on US-Russia diesel deal, Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Regeneron (NASDAQ: REGN) | Delayed: 753.12 -9.69 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $762.81 | 52 Week High | $592.36 | |||
| Open | $762.49 | 52 Week Low | $325.35 | |||
| Day High | $765.60 | P/E | 197.67 | |||
| Day Low | $743.57 | EPS | $3.81 | |||
| Volume | 624,232 | |||||
